Scientists at the University of York have harnessed the therapeutic effects of carbon monoxide-releasing molecules to develop a new antibiotic which could be used to treat the sexually transmitted infection gonorrhoea.
The scientists found that Neisseria gonorrhoeae is more sensitive to CO-based toxicity than other model bacterial pathogens, and may serve as a viable candidate for antimicrobial therapy using CO-RMs. The CO molecule works by binding to the bacteria, preventing them from producing energy.
Professor Fairlamb added: "We think our study is an important breakthrough. It isn't the final drug yet but it is pretty close to it." "People might perceive Neisseria gonorrhoeae as a trivial bacterial infection, but the disease is becoming more dangerous and resistant to antibiotics."
Scientists develop new antibiotic for gonorrhea